The introduction of generative artificial intelligence tools has created new opportunities while simultaneously challenging the traditional concept of authorship. As a leading scholarly publisher, we have been closely following these developments. Our updated Authorship Guidelines emphasize that tools such as AI chatbots (e.g., ChatGPT) and other large language models (LLMs) do not meet authorship criteria and therefore cannot be listed as authors on manuscripts. Although AI can support the writing process, it is widely acknowledged that it cannot take responsibility for the content it generates.

Authors remain fully responsible for the originality, validity, and integrity of their manuscript and must ensure that it complies with all Indonesian Journal of Pharmacy publication ethics policies. AI technology may be used in preparing academic papers; however, such use must be transparently disclosed when submitting a manuscript to the Indonesian Journal of Pharmacy.

In these cases, authors are required to clearly state, in the Acknowledgments section, which AI tools were used, and to describe in detail, in the Materials and Methods section, how these tools contributed to the manuscript. Our updated guideline aligns with the Committee on Publication Ethics (COPE) position on the use of AI and AI-assisted technologies in manuscript preparation, which states that “authors are fully responsible for the content of their manuscript, including any parts generated by AI tools, and are therefore accountable for any breaches of publication ethics.”

Each author is required to declare the use of AI in the preparation of the manuscript.